Markets.com Logo

MBIO

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    1.5672$
  • Previous Close
    1.6844$
  • 52 Week Change
    18.04$
  • Day Range
    -0.12$
  • 52 Week High/Low
    0.952$ - 18.995$
  • Dividend Per Share
    --
  • Market cap
    11 945 K$
  • EPS
    -0.19
  • Beta
    2.229
  • Volume
    --

About

MBIO.US represents Mustang Bio, Inc., a clinical-stage biopharmaceutical company focused on developing cell and gene therapies for hematologic cancers, solid tumors, and rare genetic diseases. Their therapeutic approaches involve CAR-T cell therapies and gene therapies designed to harness the power of the patient's own immune system or correct genetic defects. The company's pipeline includes several ongoing clinical trials evaluating the safety and efficacy of their product candidates in various indications. Mustang Bio collaborates with leading medical institutions to advance their research and development efforts.

Gold's Safe-Haven Status Under Scrutiny: Market Dynamics and Price Outlook

Emma Rose|--

Trump's Iran War Exit Without a Deal: Reshaping Middle East Energy Security and Power Dynamics

Emma Rose|--
European market insights: What is the European stock market doing right now?

European market insights: What is the European stock market doing right now?

Ghko B|--
EUR/USD Analysis Today: EUR/USD Gains to 1.1550 as Middle East Uncertainty Lingers

EUR/USD Analysis Today: EUR/USD Gains to 1.1550 as Middle East Uncertainty Lingers

Ghko B|--

Microsoft at a Crossroads: AI Hurdles and Cloud Resilience Amidst Market Volatility

Sophia Claire|--

Iran's Hormuz Gambit: Leveraging a Chokepoint for Economic Leverage and Global Impact

Ava Grace|--

Gold Market Resilience: Navigating Sell-offs and Sustaining Bull Run

Noah Lee|--

Factors

Here's a breakdown of factors influencing MBIO.US stock price: Company Performance: MBIO.US's revenue, earnings, and profitability directly impact investor confidence.

Industry Trends: Positive developments or downturns in the biotechnology sector influence investor sentiment towards MBIO.US.

Regulatory Approvals: Approval or rejection of MBIO.US's drugs by regulatory bodies like the FDA significantly affects its stock price.

Clinical Trial Results: Positive clinical trial outcomes boost investor optimism, while negative results lead to price declines.

Market Conditions: Overall market sentiment, economic conditions, and investor risk appetite play a role.

Competition: Actions and performance of competitors in the biotechnology space can impact MBIO.US's market position.

News & Events: Company-specific news, announcements, and major events trigger stock price fluctuations.

Investor Sentiment: Investor perception and prevailing sentiment toward MBIO.US stocks impact buying and selling pressure.

Financial Health: MBIO.US's debt levels, cash flow, and overall financial stability influence investor confidence.

Analyst Ratings: Ratings and price targets from financial analysts can drive short-term stock price movement.

People Also Watch

Latest news

US Steel and Aluminum Tariffs Revamped: Simplification Amidst Potential Cost Increases

Noah Lee|--

SpaceX Files Secret IPO Bid, Eyeing Record-Breaking $1.75 Trillion Valuation

Ava Grace|--

US Intelligence: Iran Unwilling to Engage in Substantive Talks to End War

Sophia Claire|--

Latest Education Articles

What Is Sensex in Stock Market: Meaning, Calculation, and Why It Matters for Investors

What Is Sensex in Stock Market: Meaning, Calculation, and Why It Matters for Investors

Ghko B|--
Investing basics for beginners: What are the 4 economic indicators?

Investing basics for beginners: What are the 4 economic indicators?

Frances Wang|--
CFDs vs Options: What’s the Difference?

CFDs vs Options: What’s the Difference?

Julian Parker|--